These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2103002)

  • 1. Carrier-mediated outward transport of noradrenaline from adrenergic varicosities.
    Trendelenburg U
    Pol J Pharmacol Pharm; 1990; 42(6):515-20. PubMed ID: 2103002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.
    Langeloh A; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):611-20. PubMed ID: 3444478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.
    Langeloh A; Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):602-10. PubMed ID: 3444477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of indirectly acting sympathomimetic amines.
    Trendelenburg U; Langeloh A; Bönisch H
    Blood Vessels; 1987; 24(5):261-70. PubMed ID: 3620709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
    Kress HG; Schömig E
    Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.
    Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):631-40. PubMed ID: 3444480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.
    Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):621-30. PubMed ID: 3444479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.
    Russ H; Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):286-96. PubMed ID: 1961255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of 3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in alpha-position.
    Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):433-40. PubMed ID: 2500604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
    Kurz T; Richardt G; Seyfarth M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of (+/-)-dobutamine on adrenergic nerve endings.
    Fischer P; Burger A; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):79-84. PubMed ID: 2786150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines.
    Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):135-41. PubMed ID: 3010139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for uptake1-mediated efflux of catecholamines from pulmonary endothelial cells of perfused lungs of rats.
    Westwood NN; Scarcella DL; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):528-35. PubMed ID: 8740146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens.
    Bönisch H; Fuchs G; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):131-4. PubMed ID: 3703019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart.
    Schömig A; Kurz T; Richardt G; Schömig E
    Circ Res; 1988 Jul; 63(1):214-26. PubMed ID: 3383376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathomimetic effects of MIBG: comparison with tyramine.
    Graefe KH; Bossle F; Wölfel R; Burger A; Souladaki M; Bier D; Dutschka K; Farahati J; Bönisch H
    J Nucl Med; 1999 Aug; 40(8):1342-51. PubMed ID: 10450687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the release of tritiated noradrenaline accurately reflect the release of endogenous noradrenaline from rat was deferens nerve terminals?
    Bitran M; Tapia W
    Biol Res; 1997; 30(3):105-15. PubMed ID: 9711321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.